Fundraising Fox

Cytocentrics

San Antonio, US · Founded 2014 · Delaware corporation · 1 known investors

Founders & leadership

JR
James R. GarvinChief Executive Officer, President, Secretary and Treasurer

Investors · 1

Reported raises · per SEC filings

Form D private placements

$17.4M disclosed across 2 of 3 rounds · 2015–2018

$1.5MraisedMar 2018 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alan DeanDirector
  • Paul CastellaDirector
  • James R. GarvinExecutive Officer, Director
  • Ian ClementsDirector
Offering amount
$1.5M
Amount sold
$1.5M
Sales commissions
$90K
Proceeds to insiders
$250K
Placement agents
Divine Capital Markets
First sale
Mar 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$15.8MraisedJan 2018 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ian ClementsDirector
  • James R. GarvinExecutive Officer, Director
  • Alan DeanDirector
  • Paul CastellaDirector
Offering amount
$21.8M
Amount sold
$15.8M
Sales commissions
$137.5K
Placement agents
Divine Capital Markets LLC
First sale
Mar 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
Undisclosed amountofferedMar 2015 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James R. GarvinExecutive Officer, Director
First sale
Mar 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

Who are Cytocentrics's investors?
Cytocentrics's investors include Targeted Technology Funds.
How much funding has Cytocentrics raised?
Cytocentrics has disclosed $17.4M raised across 2 of its 3 known rounds.
Where is Cytocentrics headquartered?
Cytocentrics is headquartered in San Antonio, US.